Literature DB >> 2575293

Hantavirus infections in humans and commensal rodents in Singapore.

T W Wong1, Y C Chan, Y G Joo, H W Lee, P W Lee, R Yanagihara.   

Abstract

To determine the extent of hantavirus infection in Singapore, serological studies using the indirect immunofluorescent antibody (IFA) test were conducted on commensal rodents and on human patients in 4 diagnostic groups. Virus isolation using a Vero E6 cell line was performed on hantaviral antigen-positive rodent lung tissue. Of 142 rodents and 3 insectivores studied, 37 (26%) were seropositive for IFA. Rattus norvegicus was the predominant species captured, with the highest species-specific seropositive rate of 32% (36 of 113). A hantavirus strain, R36, was isolated from one R. norvegicus. Seropositive rates for human patients were: 8% respectively for dengue haemorrhagic fever suspects and for non-A non-B hepatitis patients, 3% for leptospirosis suspects and 2% for acute nephritis patients. 2 patients had marked liver dysfunction but mild renal involvement. This hepatitis-like manifestation appears to be a clinical variant of hantavirus infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575293     DOI: 10.1016/0035-9203(89)90666-4

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  9 in total

1.  Rodent-borne hantaviruses in Cambodia, Lao PDR, and Thailand.

Authors:  Kim Blasdell; Jean François Cosson; Yannick Chaval; Vincent Herbreteau; Bounneuang Douangboupha; Sathaporn Jittapalapong; Ake Lundqvist; Jean-Pierre Hugot; Serge Morand; Philippe Buchy
Journal:  Ecohealth       Date:  2011-11-29       Impact factor: 3.184

2.  The use of anticoagulants for rodent control in a mixed-use urban environmefent in Singapore: A controlled interrupted time series analysis.

Authors:  Stacy Soh; Cliff Chua; Jane Griffiths; Penny Oh; John Chow; Qianyi Chan; Jason Tan; Joel Aik
Journal:  PLoS One       Date:  2022-05-20       Impact factor: 3.752

Review 3.  Wild Rats, Laboratory Rats, Pet Rats: Global Seoul Hantavirus Disease Revisited.

Authors:  Jan Clement; James W LeDuc; Graham Lloyd; Jean-Marc Reynes; Lorraine McElhinney; Marc Van Ranst; Ho-Wang Lee
Journal:  Viruses       Date:  2019-07-17       Impact factor: 5.048

4.  Seoul Virus Tropism and Pathology in Naturally Infected Feeder Rats.

Authors:  Miriam Maas; Melanie van Heteren; Ankje de Vries; Thijs Kuiken; Tabitha Hoornweg; Edwin Veldhuis Kroeze; Barry Rockx
Journal:  Viruses       Date:  2019-06-07       Impact factor: 5.048

5.  Survey of rodent-borne pathogens in Singapore reveals the circulation of Leptospira spp., Seoul hantavirus, and Rickettsia typhi.

Authors:  Jane Griffiths; Hui Ling Yeo; Grace Yap; Diyar Mailepessov; Patrik Johansson; Hwee Teng Low; Chern-Chiang Siew; Patrick Lam; Lee Ching Ng
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.996

6.  VKORC1 mutations in rodent populations of a tropical city-state as an indicator of anticoagulant rodenticide resistance.

Authors:  Cliff Chua; Mahathir Humaidi; Erica Sena Neves; Diyar Mailepessov; Lee Ching Ng; Joel Aik
Journal:  Sci Rep       Date:  2022-03-16       Impact factor: 4.379

7.  Molecular characterization of two hantavirus strains from different rattus species in Singapore.

Authors:  Patrik Johansson; Grace Yap; Hwee-Teng Low; Chern-Chiang Siew; Relus Kek; Lee-Ching Ng; Göran Bucht
Journal:  Virol J       Date:  2010-01-22       Impact factor: 4.099

8.  Clinical Characteristics of Ratborne Seoul Hantavirus Disease.

Authors:  Jan Clement; James W LeDuc; Lorraine M McElhinney; Jean-Marc Reynes; Marc Van Ranst; Charles H Calisher
Journal:  Emerg Infect Dis       Date:  2019-02       Impact factor: 6.883

9.  Case report: two confirmed cases of human Seoul virus infections in Indonesia.

Authors:  Khie Chen Lie; Mochamad Helmi Aziz; Herman Kosasih; Aaron Neal; Caleb Leonardo Halim; Wahyu Nawang Wulan; Muhammad Karyana; Usman Hadi
Journal:  BMC Infect Dis       Date:  2018-11-16       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.